Steven Gillis

Steven Gillis

Direktor/Vorstandsmitglied bei TAKEDA PHARMACEUTICAL COMPANY LIMITED

Vermögen: 821 664 $ am 31.05.2026

73 Jahre
Health Technology
Finance
Commercial Services

Profil

Steven H.
Gillis
founded Vilya, Inc. in 2022, Immunex Corp.
in 1981, where he worked as Director, Chief Executive & Scientific Officer from 1981 to 1994, and Corixa Corp.
in 1994, where he worked as Chairman & Chief Executive Officer from 1999 to 2005.
Dr. Gillis also currently works at HiberCell, Inc., as Chairman & Chief Executive Officer from 2025, Theraclone Sciences, Inc., as Chairman from 2011, eGenesis, Inc., as Chairman, and various other companies.
Dr. Gillis also formerly worked at Emergent Product Development Seattle, as Executive Chairman, President & CEO from 2009 to 2010, Allozyne, Inc., as Executive Chairman, Viral Logic Systems Technology Corp., as Chairman in 2009, and various other companies.
Dr. Gillis received his doctorate degree in 1978 from Dartmouth College and undergraduate degree in 1975 from Williams College.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
18.03.2026 25.557 ( 0 % ) 821 664 $ 31.05.2026

Aktive Positionen von Steven Gillis

UnternehmenPositionBeginn
TAKEDA PHARMACEUTICAL COMPANY LIMITED Direktor/Vorstandsmitglied 01.01.2019
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Vorsitzender -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Steven Gillis

UnternehmenPositionEnde
░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Steven Gillis im Detail an

Ausbildung von Steven Gillis

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

63

Beziehungen ersten Grades

59

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen59

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Steven Gillis
LETZTE CHANCE | -40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT